‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts
The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings. The recall was put in place after regulatory testing revealed the presence of three undeclared ingredients: tianeptine, 1,4-DMAA and aniracetam.
“Tianeptine can cause life-threatening events including suicidal ideation or behavior in children, adolescents, and adults aged 25 years and younger,” according to Modern Warrior. “In addition, overdose carries serious and potentially life-threatening risks including confusion, seizures, drowsiness, dry mouth and shortness of breath, which can be exacerbated by alcohol use. Using tianeptine in combination with monoamine oxidase inhibitor antidepressants could lead to life-threatening complications including stroke and death.”
Tianeptine is not approved for any medical use in the United States. In fact, the FDA has a warning about the potential harms associated with tianeptine on its website.
1,4-DMAA, meanwhile, is an amphetamine derivative associated with an increased risk of a variety of heart issues. The other ingredient, aniracetam, is not approved by the FDA as a treatment for any medical condition.
These capsules were distributed throughout the United States from April 2022 to December 2025.
“Modern Warrior has immediately ceased distribution, removed the product from sale, and quarantined all remaining inventory to prevent further distribution,” according to the announcement. “Consumers who have purchased Modern Warrior Ready should stop using the product.”
Another supplement recall due to cardiovascular concerns
The agency shared details about the recall on Jan. 9, the same day it announced that 123Herbals was recalling its Silintan supplement due to an undeclared ingredient, meloxicam.
Products containing meloxicam are not legally allowed to be marketed as dietary supplements due to the significant risks associated with taking too much. The FDA’s advisory warns that exceeding the recommended maximum daily dose of meloxicam is associated with an increased risk of “serious life-threatening events” such as blood clots, heart attacks and strokes.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.